You are here: All Products  > Athenex Out-Licenses China Rights to Keratosis/Oncology Drug for $29.5 Million

Athenex Out-Licenses China Rights to Keratosis/Oncology Drug for $29.5 Million

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products